These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Medical management of hepatorenal syndrome.
    Author: Davenport A, Ahmad J, Al-Khafaji A, Kellum JA, Genyk YS, Nadim MK.
    Journal: Nephrol Dial Transplant; 2012 Jan; 27(1):34-41. PubMed ID: 22287700.
    Abstract:
    Hepatorenal syndrome (HRS) is defined as the occurrence of renal dysfunction in a patient with end-stage liver cirrhosis in the absence of another identifiable cause of renal failure. The prognosis of HRS remains poor, with a median survival without liver transplantation of <6 months. However, understanding the pathogenesis of HRS has led to the introduction of treatments designed to increase renal perfusion and mean arterial blood pressure using vasopressors and albumin, which has led to improvement in renal function in ∼50% of patients.
    [Abstract] [Full Text] [Related] [New Search]